Lantheus at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Lantheus takes part in 1 session at CTAD 2026 in Boston. Its program covers PET imaging of astrocytic MAO-B across the Alzheimer's disease spectrum, adding to its work on brain imaging agents.

OrganizationCTAD 2026 Attendance
Lantheus
Bedford, Massachusetts
◆Gold Sponsor
lantheus.com
Biomarker & diagnostics companiesGold Sponsor
Radiopharmaceutical company supplying PET imaging agents, including tau and amyloid tracers used in Alzheimer's research and trials.
Poster
Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Lantheus

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction